What Researchers Did
Researchers reviewed the indications, contraindications, and the status of clinical and experimental hyperbaric oxygen therapy (HBOT) research in China.
What They Found
Hyperbaric oxygen therapy (HBOT) has been utilized in China for nearly 50 years as a primary or adjuvant treatment for various diseases. The review detailed the established indications and contraindications for HBOT, alongside its current clinical and experimental research status in China.
What This Means for Canadian Patients
This review provides an overview of how hyperbaric oxygen therapy is applied and researched in China, offering insights into its potential uses and limitations. While not directly applicable to Canadian healthcare practices, it contributes to the broader understanding of HBOT as a therapeutic option globally.
Canadian Relevance
This review focuses exclusively on hyperbaric oxygen therapy practices and research within China, therefore it has no direct Canadian relevance.
Study Limitations
As a review, this article's limitations include its descriptive nature and potential for selection bias in the literature examined.